Donanemab 62381-9401
Product NDC
62381-9401- Manufacturer
- Lilly France
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- January 9, 2023
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Donanemab | 17.5 mg/mL |
Packaging Options(2)
3 TRAY in 1 BOX (62381-9401-5) / 187 VIAL in 1 TRAY / 20 mL in 1 VIAL
5 TRAY in 1 BOX (62381-9401-8) / 176 VIAL in 1 TRAY / 20 mL in 1 VIAL